BioCentury
ARTICLE | Clinical News

Magellan MAR01: Phase I started

February 7, 2011 8:00 AM UTC

Arteriocyte began an open-label, U.S. Phase I trial to evaluate Magellan MAR01 in an undisclosed number of patients who are not eligible for revascularization surgery. ...